Price tag for a questionable Alzheimer’s treatment: $109,000 per patient, per year. Unclear yet: For how many years?

By SharpBrains | August 2, 2023

The real costs of the new Alzheimer’s drug, Leqem­bi — and why tax­pay­ers will foot much of the bill (CBS News): The first drug pur­port­ing to slow the advance of Alzheimer’s dis­ease is like­ly to cost the U.S. health care sys­tem bil­lions annu­al­ly even as it remains out of reach for many of the low­er-income seniors…

Read More

Education builds Cognitive Reserve for Alzheimers Disease Protection

By Dr. Pascale Michelon | December 13, 2008 |

Giv­en the grow­ing media cov­er­age men­tion­ing the terms Cog­ni­tive Reserve and Brain Reserve, you may be ask­ing your­self, “What exact­ly is my Cog­ni­tive (or Brain) Reserve?” The cog­ni­tive reserve hypoth­e­sis, test­ed in mul­ti­ple stud­ies, states that indi­vid­u­als with more cog­ni­tive reserve can expe­ri­ence more Alzheimer’s dis­ease pathol­o­gy in the brain (more plaques and tan­gles) without…

Read More